Benitec Biopharma Inc. Cash Flow Statement

Cash Flow Statement Jun2019 Jun2020 Jun2021 Jun2022 Jun2023 Jun2024 Jun2025
Operating Activities
Net Income 2.71M-8.22M-13.60M-17.89M-19.11M-21.59M-38.48M
Depreciation and Depletion 0.16M0.19M0.23M0.17M
Share-based Compensation 0.67M0.24M0.63M0.87M0.45M0.83M17.43M
Gains from Investment Securities -0.01M0.58M0.79M
Cash from Operations 4.79M-7.54M-12.83M-15.90M-18.01M-19.40M-23.60M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.18M0.19M0.23M0.24M0.26M0.33M
Amortization of Deferred Charges 0.18M0.19M0.23M0.24M0.26M0.33M
Depreciation & Amortization (CF) 0.16M0.19M0.23M0.17M0.14M0.09M0.07M
Change in Working Capital
Change in Receivables -0.61M-2.40M-0.03M-0.00M0.05M0.18M-0.20M
Change in Account Payables 0.74M-1.70M0.06M1.09M1.36M0.94M-2.38M
Change in Accured Expenses -0.01M0.06M0.12M0.08M0.07M0.04M-0.08M
Investing Activities
Capital Expenditures 0.40M0.10M0.22M0.01M0.00M0.18M0.02M
Sales of Property, Plant and Equipment 0.00M0.00M
Cash from Investing Activities -0.40M-0.09M-0.22M-0.01M-0.00M-0.18M-0.02M
Financing Activities
Other financing activities 0.48M3.23M1.87M5.89M2.32M
Change in Capital Stock
Shares Issued 2.25M25.75M17.88M70.88M30.46M
Misc.
Cash from Financing Activities 1.77M22.52M16.02M68.03M70.48M
Exchange Rate Effect -0.55M-0.06M0.50M0.20M0.41M-0.01M0.05M
Change in Cash 4.39M-5.86M9.97M-15.71M-1.59M48.44M46.93M
Free Cash Flow 4.39M-7.63M-13.05M-15.91M-18.01M-19.58M-23.62M
Net Cash Flow 4.39M-5.86M9.47M-15.91M-2.00M48.45M46.87M